Is there any Relationship between Rh(D) Blood Group and Von Willebrand Factor Antigen Concentration?
DOI:
https://doi.org/10.15379/2408-9877.2016.03.02.03Keywords:
Von willebrand factor antigen, ABO blood group, Rh(D)blood group, ELISA, UyoAbstract
Background: Several reports have documented the influence of ABO blood group on plasma von Willebrand Factor Antigen (vWF:Ag) levels. However, a thorough search through the literature has not revealed any study on the relationship between Rh blood group and plasma von Willebrand Factor antigen levels.
Objective: The aim of this study was to determine the relationship between plasma vWF:Ag levels and Rh(D) blood group among apparently healthy Nigerian subjects.
Methods: This was a cohort study of 100 Blood Donors attending the Blood Bank Unit at University of Uyo Teaching Hospital, Uyo, Nigeria. Plasma vWF:Ag levels were determined by ELISA method while the ABO and Rh(D) blood group phenotypes were determined using the standard tube method. The data were analyzed with SPSS version 16.0. Chi square was used for test of significance.
Results: The study population consisted of 63 (63%) males and 37 (37%) females with a mean age of 31.7 ± 6.39 years. The frequency of Rh(D) positive and Rh(D) negative blood groups were 95% and 5%, respectively. The mean plasma vWF:Ag concentration of the subjects was 1.38 ± 1.02 IU/ml. Group B Rh(D) positive subjects had the highest mean vWF:Ag level (2.27 ± 1.57 IU/ml), followed by group O Rh (D) negative (2.00 ± 1.04 IU/ml), group AB Rh(D) positive (1.69 ± 1.06 IU/ml), group B Rh(D) negative (1.53 ± 0.57 IU/ml), group O Rh(D) positive (1.24 ± 1.00 IU/ml) and group A Rh(D) positive (1.08 ± 0.40 IU/ml) having the lowest level.
Conclusion: There was no statistically significant association between the plasma vWF:Ag levels and Rh(D) blood groups of study subjects (P = 0.1546). However, further research with larger sample size is required to determine the relationship between plasma vWF:Ag levels and Rh blood group in general before reaching definite conclusion about the lack of influence of Rh blood group on the plasma level of vWF:Ag.
References
Landsteiner K, Wiener As. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc Soc Exp Biol Med 1940; 43: 223. http://dx.doi.org/10.3181/00379727-43-11151
Le Van Kim C, Cherif – Zahar B, Raynal V, Cherrier C, Cartron J-P, Colin Y. molecular cloning and a primary structure of the human blood group RhD polypeptide. Proc. NatL. Acad. Sol. USA 1992; 89: 10925-10929. http://dx.doi.org/10.1073/pnas.89.22.10925
Simse S, de Jong CAM, Overbeeke MAM. Sequence analysis of cDNA derived from reticulocyte mRNAS coding for Rh polypeptides and demonstration of E/e and C/c polymorphisms. Vox. Sang. 1994; 67: 203-209. http://dx.doi.org/10.1111/j.1423-0410.1994.tb01661.x
Story JR. Human blood groups: inheritance and importance in transfusion medicine. J Infus Nurs 2003; 26: 367-72. http://dx.doi.org/10.1097/00129804-200311000-00006
Molison PL. Blood transfusion in clinical medicine. Blackwell Scientific Publication 1979; 6.
Urbaniak SJ, Greiss MA. RhD haemolytic disease of the fetus and the newborn. Blood Rev 2000; 14: 44-61. http://dx.doi.org/10.1054/blre.1999.0123
Stella TC, Tannoa J, Connie MW, David FF. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh – matched minority donors. Blood 2013; 122: 1062-1071. http://dx.doi.org/10.1182/blood-2013-03-490623
Khan MS, subhand F, sultans Prevalence of blood groups and Rh factor in Bantu region NWFP (Pakistan). Pak J Med Res 2004; 43: 8-10.
Khaliq MA, khan JA, Shah H, Khan SP. Frequency of ABO and Rh (D) blood group in Hazara division (Aboottabad). Pak J med Res 1984; 23: 102-103.
Reid ME, Bird GW Associations between human red cell blood group antigens and disease. Transfuse med Rev 1990; 4: 47-55.
De Meyer SF, Deckmyn H, Vanhoorelbeke K. Von Willebrand Factor to the rescue. Blood 2009; 113: 5049-57. http://dx.doi.org/10.1182/blood-2008-10-165621
Sadler JE, Budde U, Elkenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. The working party on von Willebrand disease classification: update on the pathophysiology and classification of von Willebrand disease. J Thromb Haemost 2006; 4: 2103-14. http://dx.doi.org/10.1111/j.1538-7836.2006.02146.x
Orstavik KH, magnus P, Reiner H, Berg K, Graham JB. Factor VIII and Factor IX in a twin population: evidence for a major effect of ABO locus on Factor VIII level. am J Hum Geret 1985; 37-101.
Nitu-Whalley IC, Lee CA, Griffixen A, Pasi KJ. Type/ von Willebrand disease – a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history. Br J Haematol 2000; 108: 259-64. http://dx.doi.org/10.1046/j.1365-2141.2000.01830.x
Levy GG, Ginsburg D. Getting at the variable expressivity of von Willebrand disease. Blood 2004; 69: 1691-5.
Gill JC, Endress – Brooks J, Bauer PJ. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 2004; 292: 1691-1695.
Werner EJ, Broxson EH, Tucker EI. Prevalence of von Willebrand disease in children: a multiethnic study J Pediatr 1993; 123: 893-8. http://dx.doi.org/10.1016/S0022-3476(05)80384-1
National population commission (NPC) [Nigeria]. Nigeria Demogrpahic and Health survey 2013. Uyo, Nigeria: National Population Commission.
Bain BJ, Lewis SM, Bates I. Basic Haematological Techniques. In: SM Lewis, BJ Bain, I Bates (Eds). Dacie and Lewis Practical haematology 11th Philadelphia Churchill Livingstone 2008; 36-39.
Laffan M, Brown SA, Collins PVV, et al. The diagnosis of von Willebrand disease. A guideline from the UK Haemophilia centre Doctors' Organization Haemophilia 2004; 10: 199-217. http://dx.doi.org/10.1111/j.1365-2516.2004.00894.x
Weiss HJ, Ball AP, Mannucci PM. Incidence of severe von Willebrand's disease. N Eng I J med 1982; 307: 127. http://dx.doi.org/10.1056/NEJM198207083070221
Kumari M, Gaunt T. Genetic variable associated with von Willebrand Factor levels in healthy men and women identified using the human CVD bactrip. Annals of Human Genetics 2011; 456-467.
Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand Factor by ADAMTS13. J Thromb Haemost 2003; 1:33-40. http://dx.doi.org/10.1046/j.1538-7836.2003.00007.x
Matsui T. Titani K, Mizuochi T. Structures of the asparagines – linked oligosaccharide chains of human vWF. Occurrence of blood group A, B and H (D) structures. J Biol chem 1992, 267: 8723-31.
Downloads
Published
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .